Disease management

The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.

The San Francisco-based digital musculoskeletal care company filed to go public on Monday and will list under the ticker symbol HNGE.

The MSK company will use the funds to expand its value-based care initiatives and advance its technology and clinical programs.

It is also expected to offer a new digital weight loss program.  

The New York-based company also reported a 110% increase in fourth-quarter revenue in 2024 compared to Q4 2023 and a Q4 2024 net loss of $9.6 million. 

Also, Heuron started expanding to Japan following an exclusive deal to supply its stroke imaging AI.

Also, a new online platform providing rural doctors support and resources on allergies went live.  

Dr Ben Ng, chief medical advisor of ORA Group, explains how a hybrid model ensures the highest quality of care delivery.  

Aubrey May Agcon, clinical research nurse at NY Department of Health and Mental Hygiene, joined MobiHealthNews to discuss her HIMSS25 talk on how appropriate triage influences patient outcomes and resource utilization.   

Curai Health will provide virtual care to participants to help researchers compare the accuracy of at-home tests with PCR lab tests in detecting current COVID-19 and influenza strains.